NCT03653013 is a NA clinical trial of Usual standard of care in Diabetes, sponsored by NYU Langone Health.

Who is sponsoring NCT03653013?

NCT03653013 is sponsored by NYU Langone Health.

What drugs are being tested in NCT03653013?

Interventions in NCT03653013: Usual standard of care, Neuropsychological Consultation.

What condition does NCT03653013 study?

NCT03653013 studies Diabetes, Glycinemia.

Is NCT03653013 still recruiting?

NCT03653013 is currently completed. Last updated 24 August 2023.

Last reviewed 2023-08-24 · How we verify

NCT03653013

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Neuropsychological Consultation as Part of Pediatric Diabetes Care: Does it Improve Glycemic Control and Family Functioning?

Completed NA Last updated 24 August 2023

What this trial tests

NA trial testing Usual standard of care in Diabetes in 50 participants. Completed in 1 August 2023.

Timeline

16 July 2019

Primary endpoint
1 August 2022

1 August 2023

Quick facts

Lead sponsor	NYU Langone Health
Phase	NA
Status	Completed
Study type	INTERVENTIONAL
Allocation	randomized
Design	parallel
Masking	none
Primary purpose	treatment
Enrollment	50
Start date	16 July 2019
Primary completion	1 August 2022
Estimated completion	1 August 2023
Sites	1 location across United States

Drugs / interventions tested

Usual standard of care
Neuropsychological Consultation

Conditions studied

Diabetes — all drugs for Diabetes →
Glycinemia — all drugs for Glycinemia →

Sponsor

NYU Langone Health — full company profile →

Who can join

Adults 10 to 18, any sex, with Diabetes or Glycinemia. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

This is a randomized controlled open label study design (study team will not be blinded) to measure whether including targeted neuropsychological consultations as part of pediatric diabetes care informs treatment and educational planning, improves glycemic control, and improves quality of life. Patients will be randomized 1:1 ratio to Group 1-Control group and Group 2-Neuropsychological consultation group.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other trials of Usual standard of care

Trials testing the same drug.

NCT05156762 — Total Joint Arthroplasty (TJA) Weight Loss Study · NA · terminated
NCT05200585 — Pilot of Lifestyle Behavior Intervention for Non-Alcoholic Fatty Liver Disease · NA · completed
NCT04336176 — Evaluating Plantar Foot Pressure in a Novel Diabetic Offloading Device · NA · completed

Other recruiting trials for Diabetes

Currently open trials in the same condition.

NCT07272837 — Impact of Semaglutide (Ozempic/Wegovy®) on Heart and Muscle Mass · recruiting
NCT07479134 — Production of Stem Cells for the Generation of Pancreatic Cells · NA · recruiting
NCT07441655 — Families Implementing Good Health Traditions for Life · NA · recruiting
NCT06724172 — CHIME: Comparing Health Interventions for Maternal Equity · NA · recruiting
NCT07417865 — ECHO Diabetes FQHC · recruiting

Other NYU Langone Health trials

Trials by the same sponsor.

NCT07214519 — Permanent Supportive Housing Overdose Prevention-2 Study · NA · not yet recruiting
NCT05558267 — Potassium Containing Salt-Substitute in Hemodialysis-Dependent End Stage Kidney Disease · NA · not yet recruiting
NCT06637852 — Sexual and Urinary Function Improvement for Cancer Survivors · NA · not yet recruiting
NCT06236087 — Overdose Prevention Centers and Behavioral Health · not yet recruiting
NCT06462027 — Packed Red Blood Cell Transfusion During Cardiac Arrest · Phase 1 · suspended

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT03653013 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by NYU Langone Health
Last refreshed: 24 August 2023

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03653013.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing